These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Survey of sterile product compounding practices in Canadian hospital pharmacies. Fitch DP; Hall KW Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343 [TBL] [Abstract][Full Text] [Related]
3. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies. Kastango ES JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322 [TBL] [Abstract][Full Text] [Related]
4. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797]. Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206 [TBL] [Abstract][Full Text] [Related]
5. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists. Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883 [No Abstract] [Full Text] [Related]
6. Implementing United States Pharmacopeia Chapter <1163>: Quality assurance in pharmaceutical compounding, part 4: cleaning and packaging. Allen LV Int J Pharm Compd; 2012; 16(5):405-14. PubMed ID: 23072201 [TBL] [Abstract][Full Text] [Related]
7. Implementing United States Pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, Part 1. Allen LV Int J Pharm Compd; 2012; 16(2):146-9. PubMed ID: 23050327 [TBL] [Abstract][Full Text] [Related]
8. Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4. Allen LV Int J Pharm Compd; 2012; 16(1):64-8. PubMed ID: 23050315 [TBL] [Abstract][Full Text] [Related]
9. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding. Hyde TD Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341 [TBL] [Abstract][Full Text] [Related]
10. Misinterpretations of United States pharmacopeia chapter <797>. McElhiney LF Int J Pharm Compd; 2012; 16(1):6-10. PubMed ID: 23050305 [TBL] [Abstract][Full Text] [Related]
11. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals. Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471 [TBL] [Abstract][Full Text] [Related]
12. Draft guidelines on quality assurance for pharmacy-prepared sterile products. Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008 [No Abstract] [Full Text] [Related]
13. Implementing United States Pharmacopeia Chapter <1163> quality assurance in pharmaceutical compounding, Part 5: Outsourcing and responsible personnel. Allen LV Int J Pharm Compd; 2012; 16(6):490-6. PubMed ID: 23259367 [TBL] [Abstract][Full Text] [Related]
15. Commercial premixed parenteral nutrition: Is it right for your institution? Miller SJ Nutr Clin Pract; 2009; 24(4):459-69. PubMed ID: 19605800 [TBL] [Abstract][Full Text] [Related]
16. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists. Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879 [No Abstract] [Full Text] [Related]
18. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related]
19. Implementing United States pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, part 2: documentation and verification. Allen LV Int J Pharm Compd; 2012; 16(3):230-4. PubMed ID: 23050301 [TBL] [Abstract][Full Text] [Related]